Market Cap (In USD)
49.14 Million
Revenue (In USD)
-
Net Income (In USD)
-19.77 Million
Avg. Volume
141.48 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.98-5.99
- PE
- -
- EPS
- -
- Beta Value
- 0.34
- ISIN
- US5526411021
- CUSIP
- 552641102
- CIK
- 1878313
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Vlad Vitoc M.B.A., M.D.
- Employee Count
- -
- Website
- https://www.MAIABiotech.com
- Ipo Date
- 2022-07-28
- Details
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
More Stocks
-
BESTAGROBEST AGROLIFE LIMITED
BESTAGRO
-
HADVHealth Advance Inc.
HADV
-
7607Shinwa Co., Ltd.
7607
-
PERIPerion Network Ltd.
PERI
-
STOHFEquinor ASA
STOHF
-
0QLT
-
EBC
-
SSMS